002940 logo

Zhejiang AngLiKang Pharmaceutical CO.,LTD. Stock Price

SZSE:002940 Community·CN¥5.9b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

002940 Share Price Performance

CN¥0
-13.19 (-100.00%)
CN¥0
-13.19 (-100.00%)
Price CN¥0

002940 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet with acceptable track record.

3 Risks
1 Reward

Zhejiang AngLiKang Pharmaceutical CO.,LTD. Key Details

CN¥1.4b

Revenue

CN¥899.4m

Cost of Revenue

CN¥547.3m

Gross Profit

CN¥439.2m

Other Expenses

CN¥108.1m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Apr 29, 2026
0.55
37.83%
7.47%
25.7%
View Full Analysis

About 002940

Founded
2001
Employees
1275
CEO
Guo Gang Zheng
WebsiteView website
www.alkpharm.com

Zhejiang AngLiKang Pharmaceutical CO.,LTD., a pharmaceutical company, engages in manufacturing APIs and pharmaceutical preparations for oral cephalosporins, cardiovascular, and kidney diseases. The company also offers products in the areas of anti-infection, cardiovascular, urinary system (nephropathy), anesthesia and pain, and anti-androgen. The company was founded in 2001 and is based in Shengzhou, China.

Recent 002940 News & Updates

Recent updates

No updates